|EPGNF -- USA Stock|| |
USD 2.68 0.0029 0.11%
Dr. Uwe Staub resigned as Chief Operating Officer at Epigenomics AG with effect from March 31, 2018, a position he has held since April 1, 2013. Prior to that, he served as Senior Vice President Research and Development Manufacturing of the Company from November 1, 2008. He was also granted procura and will take over the responsibility for medical affairs and customer support of the Company. Before joining the Company, Dr. Staub worked 14 years in the IVD industry for Abbott Diagnostics, Digene and Qiagen and gained experience in Operations, Quality and Regulatory Affairs as well as Product Development. He studied Biology at the JuliusMaximiliansUniversitaet Wuerzburg, Germany, and earned his Ph.D. degree in Biochemistry and Human Genetics.
COO Since 2013 Ph.D
49 30 243 450 http://www.epigenomics.com